Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents
Sponsor: Fundació Sant Joan de Déu
Summary
This study investigates the effects of a postbiotic combination called ABB C3 on reducing body fat and improving metabolic health in children and teenagers. The study consists of a 3-month trial with half participants taking ABB C3 and the other half a placebo, monitoring body composition and blood markers. Afterward, participants can continue with ABB C3 for an additional 3 months. The goal is to determine if ABB C3 is a safe and effective way to help young people improve their health by reducing body fat.
Key Details
Gender
All
Age Range
8 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2024-04-10
Completion Date
2026-06-30
Last Updated
2026-03-23
Healthy Volunteers
No
Conditions
Interventions
Postbiotic ABB C3
A daily dose of 550 mg of the postbiotic blend ABB C3 in individual sachets for the first 3 months of the study.
Placebo
A daily dose of 550 mg of the placebo in individual sachets for the first 3 months of the study.
Follow-up Postbiotic ABB C3 (Optional)
Option given to all participants: a daily dose of 550 mg of the postbiotic blend ABB C3 in individual sachets for months 4 to 6 of the study.
Locations (1)
Hospital Sant Joan de Déu
Barcelona, Barcelona, Spain